Guidance

Gonococcal resistance to antimicrobials surveillance programme (GRASP) protocol

Information and procedural guidance for the national gonococcal surveillance programme.

• From: UK Health Security Agency
• Published: 1 April 2014
• Last updated: 10 May 2023 — See all updates

Documents

GRASP protocol

HTML

Details

Surveillance of antimicrobial resistance is critical in shaping national treatment guidelines to ensure appropriate patient management. The gonococcal resistance to antimicrobials surveillance programme (GRASP), a national sentinel surveillance programme, was established in 2000 to monitor trends and drifts in susceptibility to antimicrobial agents used for the treatment of gonorrhoea in England and Wales.

This document details the background, objectives and methods of GRASP.

Further data on antimicrobial resistance (AMR) in N. gonorrhoeae is available in the annual GRASP reports.

Published 1 April 2014
Last updated 10 May 2023 + show all updates

1. 10 May 2023

   Updated distribution of clinic and laboratory-specific reports, terminology, and links in the GRASP protocol.

2. 21 November 2022

   Updated standard operating procedure, terminology, and links in the GRASP protocol.

3. 18 November 2020

   Updated GRASP protocol.

4. 1 April 2014

   First published.